KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $16.16 $18.63 Thursday, 25th Apr 2024 ACAD stock ended at $16.31. This is 1.69% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.17% from a day low at $16.16 to a day high of $16.51.
90 days $16.16 $27.94
52 weeks $16.16 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Aug 15, 2023 $28.07 $28.74 $27.76 $28.72 1 205 512
Aug 14, 2023 $27.29 $28.31 $26.57 $28.01 1 336 224
Aug 11, 2023 $26.60 $27.54 $26.56 $27.37 917 551
Aug 10, 2023 $26.63 $26.77 $26.28 $26.65 1 079 276
Aug 09, 2023 $26.72 $26.72 $26.11 $26.59 1 002 808
Aug 08, 2023 $26.83 $27.15 $26.45 $26.72 1 319 859
Aug 07, 2023 $27.17 $27.17 $26.52 $26.80 1 398 949
Aug 04, 2023 $27.20 $27.48 $26.95 $27.19 1 559 298
Aug 03, 2023 $27.98 $28.29 $27.04 $27.20 3 738 181
Aug 02, 2023 $28.75 $29.53 $28.71 $29.20 1 707 063
Aug 01, 2023 $29.25 $29.34 $28.66 $28.94 1 862 853
Jul 31, 2023 $29.23 $29.74 $28.91 $29.24 1 768 882
Jul 28, 2023 $28.75 $29.24 $27.90 $29.04 3 179 807
Jul 27, 2023 $29.48 $29.48 $28.82 $29.02 950 770
Jul 26, 2023 $29.59 $29.61 $29.02 $29.16 963 261
Jul 25, 2023 $29.94 $30.26 $29.50 $29.60 1 128 328
Jul 24, 2023 $30.88 $30.92 $29.93 $30.02 1 578 999
Jul 21, 2023 $31.59 $31.60 $30.63 $30.80 2 631 399
Jul 20, 2023 $31.96 $32.29 $31.03 $31.26 2 385 793
Jul 19, 2023 $33.06 $33.13 $31.47 $31.91 2 205 810
Jul 18, 2023 $33.61 $33.91 $32.90 $32.99 2 376 252
Jul 17, 2023 $32.74 $33.74 $31.90 $33.47 3 629 847
Jul 14, 2023 $30.07 $32.89 $28.75 $32.18 9 339 496
Jul 13, 2023 $25.92 $26.09 $25.69 $25.80 1 214 415
Jul 12, 2023 $25.00 $26.06 $24.95 $25.86 1 401 011
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT